BNET Industries
Last Fiscal Year Sales:$1.2B
- Private
- US
Dow Jones Description
MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on cardiovascular/gastrointestinal disease, neuroscience, oncology, infection, respiratory disease and inflammation. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN).
President & Chief Executive OfficerDavid M. Mott
Number of Employees 3,000
Contact Information
35 W Watkins Mill Rd
Gaithersburg, Maryland 20878-4021
(301) 417-0770
Peer Companies
NAICS Code Research and Development in the Social Sciences and Humanities: 541720
Recent Events
-
Ignore Icahn's Hoopla
-
MedImmune Lands Swine Flu Vaccine contract from US Health Dept
-
Baltimore seeks ideas for $1B redevelopment
-
Vaccine Would Be Spoken For: Rich Nations Have Preexisting Contracts
-
Eagle Materials CFO steps down
-
Genaera Corporation - Financial and Strategic Analysis Review
-
13D Filings
-
Medarex to receive $1 million milestone payment from MedImmune
-
Xenome Ltd Grants MedImmune License to xdiscoverTM Venom Peptide Library
News & Analysis
Filter by
medimmune inc. - All News and Analysis
Pharma Roundup: Infinity and AstraZeneca Split, Schering & Merck's PR Blunder, and More
A fond farewell between Infinity and AstraZeneca, a dubious PR honor for S-P and Merck over Vytorin, Lilly's ImClone-related costs mount, generics cost less. by John Maas
How Not to Do An Acquisition: AstraZeneca-MedImmune
When AstraZeneca ponied up more than $15 billion for the biotech MedImmune just over a year ago, the deal suggested that desperate Big Pharmas were willing to open their wallets wide for biotechs without looking too closely into the question of whether they were really worth the money. As I...
DIREVO announces transfer of patents from Evotec
DIREVO Biotech AG announced today that it has entered into an agreement with Evotec under which Evotec will transfer certain patents to DIREVO that are currently licensed by DIREVO. Such patents protect key components of DIREVO's unique and proven protein/strain engineering platform. Using this platform, DIREVO develops products both independently...
Hiring underway at Gaithersburg-based MedImmune
MedImmune Inc., of Gaithersburg, a biotechnology company focused on developing and manufacturing products to combat infectious disease, autoimmune disease and cancer, announced that it is looking to fill more than 800 jobs, mostly in research and development and clinical positions, by the end of the year, expanding its work force...
News Summary - 4/16
United BioSource acquisition United BioSource Corp., of Bethesda, a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products, announced its acquisition of Envision Pharma, a scientific communications and technology company based in Horsham, U.K., with offices in Southport and Glastonbury,...
Gaithersburg-based MedImmune drug advances
MedImmune Inc., of Gaithersburg, a biotechnology company focused on developing and manufacturing products to combat infectious disease, autoimmune disease and cancer, announced the start of two new clinical trials as part of its efforts to develop CAT-354, an antibody that MedImmune sees as a potential treatment for patients with asthma....
Pinnacle Biologics Announces Marketing and Distribution Agreement With MedImmune.
ROCKVILLE, Maryland, February 19 /PRNewswire/ -- ROCKVILLE, Maryland, February 19 /PRNewswire/ --
MedImmune Submits Biologics License Application to FDA for Motavizumab.
GAITHERSBURG, Maryland, February 4 /PRNewswire/ -- GAITHERSBURG, Maryland, February 4 /PRNewswire/ --
Research and Markets: SWOT Analysis Tool to Evaluate the Strengths, Weaknesses, Opportunities, and Threats of MedImmune
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79606) has announced the addition of "MedImmune - SWOT Framework Analysis" to their offering.
Research and Markets: MedImmune Inc - Product Pipeline Report
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c78543) has announced the addition of MedImmune Inc - Product Pipeline Report to their offering.
Those who viewed this also viewed...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| David M. Mott | President & Chief Executive Officer |
| James Young | President, Res & Development |
| Alex Zukiwski | Senior Vice President, Clinical Research & Chief Medical Officer |
| Lota S. Zoth | CFO, Vice President, Vice President & Controller |
| William C. Bertrand Jr. | General Counsel, Chief Compliance Officer, Senior Vice President & Secretary |
| Edward M. Connor | Executive Vice President |
| Edward T. Mathew | Executive Vice President, Corp Development & Venture |
| Peter A. Kiener | Executive Vice President, Research |
| Andrew D. Skibo | Senior Vice President, Engineering |
| Armando Anido | Senior Vice President, Commercial Operations |
| Bernardus N. M. Machielse | Senior Vice President, Operations |
| Edward J. Arcuri | Senior Vice President, Manufacturing Operations |
| Frank J. Malinoski | Senior Vice President, Medical and Scientific Affairs |
| Gail Folena-Wasserman | Senior Vice President, Development |
| Pamela J. Lupien | Senior Vice President, HR |
| Peter Greenleaf | Senior Vice President, Marketing and Sales |
| Allan Darling | Vice President, Corp Quality Control |
| Anthony Luttrell | Vice President, Quality |
| Bahija Jallal | Vice President, Translational Science |
| Caroline York | Vice President, Govt Affairs & Reimbursement |
| Charles F. Katzer | Vice President, Vaccine Manufacturing |
| David W. Robinson | Vice President, Oncology Sales & Marketing |
| Dirk Reitsma | Vice President, Clinical Development, Oncology |
| Douglas B. Willner | Vice President, Sales Training |
| Edward T. Mathers | Vice President, Corporate Development |
| Eric I. Tsao | Vice President, Process & Manufacturing Services |
| Francois Lebel | Vice President, Medical Affairs |
| Frank D. Czworka | Vice President, Sales & Infectious Disease |
| Gary B. Ebbert | Vice President, Antibody & Small Molecule Manufacturing |
| Genevieve Losonsky | Vice President, Clinical Development & Infectious Disease |
| George Kemble | Vice President, Viral Vaccines Res |
| James M. Pluda | Vice President & Group Leader, Clinical Development |
| James Miller | Vice President, Intl Business Analysis & New Prod |
| Jeffrey S. Hackman | Vice President, Marketing |
| John Brandt | Vice President, Corp Quality Control |
| John J. Trizzino | Vice President, Trade & Distr |
| John J. Whalen | Vice President, Clinical Development & Operations |
| Kevin McNelly | Vice President, Supply Chain Operations |
| Kevin Rooney | Vice President, Sales & Marketing |
| Lori Weiman | Vice President, Corp Communications |
| Luz D. Hammershaimb | Vice President, Clinical Development |
| Mark C. Twyman | Vice President & General Manager, Vaccines |
| Mark E. Spring | Vice President, Finance & Controller |
| Mauricio Vargas-Cortes | Vice President, Project Management |
| Michael Cowan | Vice President, Corp Quality Assurance |
| Peter A. Patriarca | Vice President, Regulatory Affairs |
| Peter Young | Vice President, Info Technology |
| Randall M. Turner | Vice President, Engineering & Facilities |
| Robert H. Earhart | Vice President, Clinical Development |
| Robert L. Hirsch | Vice President, Medical Affairs |
| Robert Walker | Vice President, Clinical Development & Inflammatory Disease |
| Sam Yonren | Vice President, Prod Safety |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| David Baltimore | Board of Directors |
| Elizabeth Wyatt | Board of Directors |
| George M. Milne Jr. | Board of Directors |
| Gordon S. Macklin | Board of Directors |
| M. James Barrett | Board of Directors |
| Melvin D. Booth | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | President & Chief Executive Officer | Current |
| Rib-X Pharmaceuticals | Chief Executive Officer of Medimmune | Current |
| Maryland Angels Council | Director | Current |
| MedImmune, Inc. | Vice Chairman | Current |
| Shire plc | Board of Directors | Current |
| Biotechnology Industry Organization | Board of Directors | Current |
| Rib-X Pharmaceuticals | Board of Directors | Current |
| MedImmune, Inc. | Board of Directors | Former |
| Dartmouth College | Bachelor's Degree In Economics | Former |
| Biotechnology Industry Organization | member | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | President, Res & Development | Current |
| The Cleveland Clinic | Medical Director | Current |
| E-Cleveland Clinic | Current | |
| Iomai Corporation | Director | Current |
| Xencor, Inc. | Director | Current |
| Arriva Pharmaceuticals, Inc. | Director | Current |
| American College of Chest Physicians | Fellow | Current |
| American College of Cardiology | Fellow | Current |
| Xencor, Inc. | Co-Founder | Former |
| Methodist Hospital | Scientific Director | Former |
| Baylor College of Medicine | Scientific Director | Former |
| Baylor College of Medicine | Clinical Coordinator | Former |
| Methodist Hospital | Clinical Coordinator | Former |
| Baylor College of Medicine | Doctorate In Microbiology | Former |
| California Institute of Technology | Ph.D. In Chemistry | Former |
| Villanova University | Bachelor of Science Degrees In Biology | Former |
| The Johns Hopkins University | Biomedical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Senior Vice President, Clinical Research & Chief Medical Officer | Current |
| Ortho Biotech Inc. | Vice President, Oncology, Ortho Biotech Products | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | CFO, Vice President, Vice President & Controller | Current |
| MedImmune, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | General Counsel, Chief Compliance Officer, Senior Vice President & Secretary | Current |
| Medlmmune Ventures, Inc. | Senior Vice President, Legal Affairs | Current |
| Braincells, Inc. | Senior Vice President | Current |
| Medlmmune Ventures, Inc. | General Counsel | Current |
| Braincells, Inc. | Board of Directors | Current |
| Pharmacia Corporation | Litigation Counsel | Former |
| University of Wisconsin-Madison | Juris Doctorate | Former |
| University of Wisconsin | Juris Doctorate | Former |
| Wayne State University | Bachelor of Science Degree In Biology | Former |
| Organization | Position | Status |
|---|---|---|
| Medlmmune Ventures, Inc. | Chief Medical Officer | Current |
| MedImmune, Inc. | Executive Vice President | Current |
| Medlmmune Ventures, Inc. | Executive Vice President | Current |
| Sequoia Pharmaceuticals Inc | Board of Directors | Current |
| Medlmmune Ventures, Inc. | Director of Clinical Studies | Former |
| University of Pennsylvania School of Medicine | Doctorate | Former |
| Villanova University | bachelor's degree in biology | Former |
| University of Pennsylvania School of Medicine | Medical Degree | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Executive Vice President, Corp Development & Venture | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Executive Vice President, Research | Current |
| Vlst Corp | Senior Vice President, Research | Current |
| Vlst Corp | Board of Directors | Current |
| Bristol-Myers Squibb Company | Director | Former |
| Lancaster University | B.S. Degree | Former |
| Lancaster University | Degree With Honors In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Senior Vice President, Engineering | Current |
Armando Anido has served as one of our directors since July 2006 and Chief Executive Officer and President since July 2006. Since August 2003, Mr. Anido has served as a director of Adolor Corporation and currently serves as Chairman of the Governance and Nominating Committee. Mr. Anido has over 25 years of biopharmaceutical experience. Prior to Auxilium, he was the Executive Vice President, Sales and Marketing for MedImmune, Inc., a biotechnology company focused on developing and marketing products in the therapeutic areas of cancer, infectious disease and immune regulation, where he was responsible for worldwide commercialization of their portfolio. He also served on MedImmune s Executive Committee and Product Development Committee. Prior to joining MedImmune in 1999, from 1995 to 1999, Mr. Anido was with GlaxoWellcome, Inc. where he served as Vice President, Central Nervous System Marketing after joining the company as Director, HIV Marketing. Mr. Anido was employed by Lederle Labs from 1989 to 1995 in various commercial roles, culminating as Vice President, Anti-infectives. Mr. Anido received his B.S. in Pharmacy and his M.B.A. in Marketing and Finance from West Virginia University.
| Organization | Position | Status |
|---|---|---|
| Auxilium Pharmaceuticals, Inc. | Chief Executive Officer | Current |
| Auxilium Pharmaceuticals, Inc. | President | Current |
| MedImmune, Inc. | Senior Vice President, Commercial Operations | Current |
| Auxilium Pharmaceuticals, Inc. | Principal Executive Officer, and Director | Current |
| Adolor Corporation | Director | Current |
| Auxilium Pharmaceuticals, Inc. | Board of Directors | Current |
| Product Development Corporation | Executive Vice President, Sales and Marketing | Former |
| Lederle Laboratories | Former | |
| West Virginia University | M.B.A. In Marketing and Finance | Former |
| West Virginia University | Bachelors of Science In Pharmacy | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Senior Vice President, Operations | Current |
| US Bioscience | Former | |
| University of Utrecht | master of science degree in biochemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Antex Biologics, Inc. | COO and Executive Vice President and Chief Operating Officer | Current |
| MedImmune, Inc. | Senior Vice President, Manufacturing Operations | Current |
| Rensselaer Polytechnic Institute | Ph.D. | Former |
Dr. Frank Malinoski is MedImmune's senior vice president, medical and scientific affairs. In this role, he oversees medical and scientific activities relating to marketed products, including clinical trials and medical information. Dr. Malinoski joined MedImmune as vice president, infectious disease, medical affairs in December 2005, with responsibility for MedImmune's infectious disease and vaccines group within medical affairs. Prior to joining MedImmune, Dr. Malinoski was president of TD Consultancy, a consulting practice advising industry and government clients on vaccine development issues. Previously, he worked at Oxxon Therapeutics, Inc. as chief medical officer and executive vice president of development, and at Wyeth Pharmaceuticals, where he held positions of increasing responsibility including: vice president, global business development; vice president, medical affairs; and assistant vice president, clinical affairs. Dr. Malinoski earned his Ph.D. in microbiology from Rutgers University and his M.D. from Albany Medical College. He holds a bachelor of arts degree from Colby College in Waterville, Maine.
| Organization | Position | Status |
|---|---|---|
| MedImmune Ventures, Inc. | Senior Vice President, Medical and Scientific Affairs | Current |
| MedImmune, Inc. | Senior Vice President, Medical and Scientific Affairs | Current |
| Ligocyte Pharmaceuticals, Inc. | Senior Vice President, Medical and Scientific Affairs, Medimmune Ventures | Current |
| Ligocyte Pharmaceuticals, Inc. | Board of Directors | Current |
| Oxxon Therapeutics, Inc. | Chief Medical Officer | Former |
| Oxxon Therapeutics, Inc. | Executive Vice President of Development | Former |
| Wyeth Pharmaceuticals, Inc. | Vice President, Medical Affairs | Former |
| Rutgers University | Ph.D. In Microbiology | Former |
| Albany Medical College | M.D. | Former |
| Colby College | Bachelor of Arts Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Medlmmune Ventures, Inc. | Senior Vice President, Development | Current |
| MedImmune, Inc. | Senior Vice President, Development | Current |
| Medlmmune Ventures, Inc. | Director, Development | Former |
| The Pennsylvania State University | Doctorate In Chemistry | Former |
| The Pennsylvania State University | Doctorate in Chemistry | Former |
| The Pennsylvania State University | Master's Degree in Biochemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Medlmmune Ventures, Inc. | Senior Vice President, Human Resources | Current |
| MedImmune, Inc. | Senior Vice President, HR | Current |
| Orbital Sciences Corporation | Senior Vice President of Human Resources | Former |
| International Business Machines Corporation | Team Member | Former |
| Jacksonville University | Master's Degree in Business Administration | Former |
| University of South Florida | bachelor's degree in social sciences | Former |
| Organization | Position | Status |
|---|---|---|
| Medlmmune Ventures, Inc. | Senior Vice President, Marketing and Sales | Current |
| MedImmune Ventures, Inc. | Senior Vice President, Marketing and Sales | Current |
| MedImmune, Inc. | Senior Vice President, Marketing and Sales | Current |
| Centocor, Inc. | Vice President, Gastroenterology Franchise | Former |
| Boehringer Mannheim Corporation | Sales and Marketing | Former |
| U.S. Healthcare, Inc. | Former | |
| St. Joseph's University | MBA | Former |
| Western Connecticut State University | Bachelor of Science Degree | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Corp Quality Control | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Quality | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Translational Science | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Govt Affairs & Reimbursement | Current |
| Organization | Position | Status |
|---|---|---|
| Discovery Laboratories, Inc. | Senior Vice President, Manufacturing Operations | Current |
| MedImmune, Inc. | Vice President, Vaccine Manufacturing | Current |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Former | |
| University of Wisconsin | B.S. Degree | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Oncology Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Clinical Development, Oncology | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Sales Training | Current |
| Organization | Position | Status |
|---|---|---|
| Medlmmune Ventures, Inc. | Senior Vice President, Corporate Development | Current |
| MedImmune, Inc. | Vice President, Corporate Development | Current |
| Johnson & Johnson | Former | |
| North Carolina State University | Bachelor's Degree In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Process & Manufacturing Services | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Medical Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Sales & Infectious Disease | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Antibody & Small Molecule Manufacturing | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Clinical Development & Infectious Disease | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Viral Vaccines Res | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President & Group Leader, Clinical Development | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Intl Business Analysis & New Prod | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Corp Quality Control | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Trade & Distr | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Clinical Development & Operations | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Supply Chain Operations | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Clinical Development | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President & General Manager, Vaccines | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Finance & Controller | Current |
| MedImmune, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Project Management | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Corp Quality Assurance | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Regulatory Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Info Technology | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Engineering & Facilities | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Clinical Development | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Medical Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Clinical Development & Inflammatory Disease | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Vice President, Prod Safety | Current |
Dr. David Baltimore has served as a director of the Company since June 1999. He is currently President Emeritus of and Robert Andrews Millikan Professor of Biology at the California Institute of Technology, or Caltech. From October 1997 to September 2006, Dr. Baltimore was the President of Caltech. From July 1995 to October 1997, Dr. Baltimore was an Institute Professor at the Massachusetts Institute of Technology, or MIT, and from July 1994 to October 1997, the Ivan R. Cottrell Professor of Molecular Biology and Immunology at MIT. Dr. Baltimore is a director of BB Biotech, AG, a Swiss investment company. In 1975, Dr. Baltimore was the co-recipient of the Nobel Prize in Medicine.
| Organization | Position | Status |
|---|---|---|
| Amgen Inc. | Board of Directors | Current |
| MedImmune, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Radius Inc. | Venture Partner | Current |
| Radius Ventures, LLC | Venture Partner | Current |
| Athersys, Inc. | Board of Directors | Current |
| Rib-X Pharmaceuticals | Board of Directors | Current |
| Mettler-Toledo, Inc. | Board of Directors | Current |
| Biostorage Technologies | Board of Directors | Current |
| Aspreva Pharmaceuticals Corporation | Board of Directors | Current |
| MedImmune, Inc. | Board of Directors | Current |
| MedImmune, Inc. | Director | Current |
| Conor Medsystems, Inc. | Director | Current |
| Medlmmune Ventures, Inc. | Director | Current |
| Charles River Laboratories, Inc. | Board of Directors | Current |
| Human, Inc. | President | Former |
| Strategic-LP | President | Former |
| Operations Management | President | Former |
| Pfizer Inc. | President | Former |
| Mettler Toledo International, Inc. | Executive Vice President, Strategic Planning, Operations | Former |
| Pfizer Inc. | Executive Vice President for Global Research and Development | Former |
| Mettler Toledo International, Inc. | Director | Former |
| Pfizer Inc. | Corporate Officer | Former |
| Pfizer Inc. | Director | Former |
| Massachusetts Institute of Technology | Ph.D in Organic Chemistry | Former |
| Yale University | BS In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Funds | Managing General Partner | Current |
| Medlmmune Ventures, Inc. | Corporate Financial Advisor | Current |
| MedImmune, Inc. | Board of Directors | Current |
| Astrotech Corporation | Director | Current |
| White Mountains Insurance Group, Ltd. | Board of Directors | Current |
| Funds | Director | Current |
| Martek Biosciences Corporation | Director | Current |
| FINRA | President | Former |
| McDonald & Company Securities, Inc. | Partner | Former |
| McDonald & Company Securities, Inc. | Member of the Executive Committee | Former |
| White River | Chairman | Former |
| Martek | Director | Former |
| Organization | Position | Status |
|---|---|---|
| MedImmune, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Millipore Corporation | Lead Director | Current |
| Technotv.Net | Current | |
| PRA International Inc. | Chairman of the Boards | Current |
| Genstar Capital LLC | Board of Directors | Current |
| Focus Diagnostics, Inc. | Board of Directors | Current |
| Millipore Corporation | Board of Directors | Current |
| Novascreen Biosciences Corporation | Board Member | Current |
| Cromedica | Director | Current |
| Ventria Bioscience | Board Member | Current |
| MedImmune, Inc. | Board of Directors | Current |
| Syntex Laboratories | President | Former |
| Human Genome Sciences, Inc. | President | Former |
| Human Genome Sciences, Inc. | Chief Operating Officer | Former |
| Syntex Corporation | Vice President | Former |
| Prestwick Pharmaceuticals, Inc | Chairman | Former |
| Prestwick Pharmaceuticals, Inc | Director | Former |
| PRA International Inc. | Board of Directors | Former |
| Northwest Missouri State University | Undergraduate Degree | Former |
Executive News
-
No decision yet on Auxilium drug application
-
U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX(TM) for the
-
U.S. Food and Drug Administration's Arthritis Advisory Committee
-
2 killed, dozens hurt in NC Slim Jim plant blast
-
2 missing, 41 hurt in NC Slim Jim plant collapse
-
NanoString Technologies Gets $30M
-
3 missing, 41 hurt in NC Slim Jim plant collapse
-
3 missing, 38 hurt in NC Slim Jim plant collapse
-
Two missing, 21 hurt in NC Slim Jim plant blast
-
2 missing, 21 hurt in NC Slim Jim plant collapse
-
NanoString rings up $30M in Series C
-
Three Missing in N.C. Building Collapse
-
NanoString Technologies Inc. Closes $30 Million Series C Financing to Accelerate the Commercialization of its Leading Expression Profiling Products
-
NanoString(R) Technologies Closes $30 million Series C Financing to Accelerate the...
-
NanoString(R) Technologies Closes $30 million Series C Financing to Accelerate the Commercialization of its Leading Expression Profiling Products
-
MedImmune wins $90M for swine flu vaccine
Industry Transcripts by Seeking Alpha
-
Apollo Group F3Q09 (Qtr End 5/31/09) Earnings Call Transcript
on Jun 29, 2009about APOL
-
Accenture Ltd. F3Q09 (Qtr End 05/31/09) Earnings Call Transcript
on Jun 25, 2009about ACN
-
FedEx Corp. F4Q09 (Qtr End 05/31/09) Earnings Call Transcript
on Jun 17, 2009about FDX
-
SAIC F1Q10 (Qtr End 4/30/09) Earnings Call Transcript
on Jun 03, 2009about SAI
-
Miva, Inc. Q1 2009 Earnings Call Transcript
on May 20, 2009about MIVA
IndustryTop Rated
- Was N.Y. Post's Carlucci the Reason for News America Marketing's Settlement With Floorgraphics? 60 votes
- News America Marketing Whistleblower: Clients Were Charged for Ads That Never Appeared 47 votes
- News America Marketing's Alleged Plans to Seize Safeway Account Outlined in Suit 44 votes
- Compete: Twitter Passes New York Times 40 votes
- News America Marketing Group Buys Floorgraphics Just Hours After Settling Spying Lawsuit 29 votes
